Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yidu TechSTU:0EL -1.20%43 5-Day RSI is 51.70 as of Aug. 12, 2026. GuruFocus rates STU:0EL with a GF Score™ of 43/100 and a GF Value™ of €0.66 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 694 Healthcare Providers & Services companies, Yidu Tech ranks worse than 59.37% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-08-12), Yidu Tech's 5-Day RSI is 51.70.
The industry rank for Yidu Tech's 5-Day RSI or its related term are showing as below:
STU:0EL's 5-Day RSI is ranked worse than 59.37% of 694
companies
in the Healthcare Providers & Services industry
Industry Median: 50.825
vs STU:0EL: 51.70
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Yidu Tech 5-Day RSI Related Terms
STU:0EL vs VEEV, BTSG, HQY: 5-Day RSI Comparison
For the Health Information Services subindustry, Yidu Tech's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yidu Tech 5-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yidu Tech's 5-Day RSI distribution charts can be found below:
* The bar in red indicates where Yidu Tech's 5-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yidu Tech (STU:0EL) has a 5-Day RSI of 51.70 as of Aug. 12, 2026. According to the industry distribution chart, Yidu Tech ranks #412 out of 694 companies in the Healthcare Providers & Services industry, placing it in the top 59.4%.
Is Yidu Tech's 5-Day RSI too high?
Yidu Tech's current 5-Day RSI is 51.70. The Healthcare Providers & Services industry median 5-Day RSI is 50.83. Yidu Tech's value of 51.70 is 1.7% above this industry median. Based on the distribution chart, Yidu Tech ranks #412 out of 694 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Yidu Tech has a GF Score™ of 43/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Yidu Tech's 5-Day RSI compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Yidu Tech ranks #412 out of 694 companies for 5-Day RSI. This places Yidu Tech in the lower half of its industry. The industry median 5-Day RSI is 50.83. Yidu Tech's value of 51.70 is 1.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Day RSI for a Healthcare Providers & Services company?
The median 5-Day RSI among Healthcare Providers & Services companies is 50.83, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a 5-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 5-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yidu Tech's current 5-Day RSI of 51.70 is 1.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Day RSI mean?
A high 5-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 5-Day RSI is 50.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yidu Tech's current 5-Day RSI is 51.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yidu Tech stock overvalued right now?
Based on GuruFocus' analysis, Yidu Tech (STU:0EL) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.66, compared to a current price of €0.49 — trading 25.2% below its estimated fair value. The current 5-Day RSI is 51.70 and 1.7% above the Healthcare Providers & Services industry median of 50.83. Yidu Tech's overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Day RSI calculated?
5-Day RSI is calculated from a company's financial statements. For Yidu Tech (STU:0EL), the current 5-Day RSI is 51.70 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yidu Tech (STU:0EL) Overvalued in 2026?
Based on GuruFocus' analysis, Yidu Tech stock appears to be undervalued.
The current stock price of €0.49 is trading 25.2% below its estimated GF Value™ of €0.66.
GuruFocus considers Yidu Tech to be Modestly Undervalued.
Key valuation signals for STU:0EL:
5-Day RSI: 51.70
GF Value™: €0.66 vs. price of €0.49 (25.2% below fair value)
Industry Position: 1.7% above the Healthcare Providers & Services median (#412 of 694)
No single metric tells the full story. See the STU:0EL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yidu Tech Inc offers healthcare solutions built on big data and artificial intelligence (AI) technologies. The company serves various healthcare industry participants, including hospitals, pharmaceutical, biotech, research institutions, insurance companies, etc. Its operating segments are: Big data platform and solutions, Life sciences solutions, and Health management platform and solutions. The majority of the company's revenue is generated from its Big data platform and solutions segment, which provides data intelligence platforms and data analytics-driven solutions (such as Eywa 5.0, Lingxi Intelligent Management, AI Middleware, etc.) for hospitals, healthcare institutions, regulators, and policymakers. Geographically, the company generates maximum revenue from Mainland China.
43GF Score
Get the complete analysis for STU:0EL
5-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:0EL has been successfully added to your 
